Alliance Pharma (LON:APH) Stock Rating Lowered by Berenberg Bank

Alliance Pharma (LON:APH) was downgraded by research analysts at Berenberg Bank to a “hold” rating in a report released on Wednesday, Marketbeat reports. They presently have a GBX 6,250 ($77.62) price target on the stock, down from their prior price target of GBX 7,000 ($86.93).

Alliance Pharma Stock Up 0.2 %

Shares of LON:APH opened at GBX 61.20 ($0.76) on Wednesday. The business’s 50-day moving average is GBX 50.26 and its 200-day moving average is GBX 44.25. Alliance Pharma has a 1 year low of GBX 24.55 ($0.30) and a 1 year high of GBX 61.60 ($0.77). The company has a market capitalization of £330.83 million, a price-to-earnings ratio of -1,020.00, a P/E/G ratio of 1.04 and a beta of 0.67. The company has a debt-to-equity ratio of 47.46, a current ratio of 2.93 and a quick ratio of 1.42.

Alliance Pharma Company Profile

Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. The company also offers medicines, medical devices, food supplements, and cosmetics.